Farah Itani is an immunologist with extensive research experience specializing in T cell and myeloid biology related to inflammatory diseases. They held positions as Senior Scientist in Immuno-Oncology at Alector and Scientist in Cellular Immunology at Johnson & Johnson Innovative Medicine before becoming the Translational Oncology Lead at Pfizer in 2023. Farah earned a Ph.D. from the University of Iowa and a Master's degree from Grand Valley State University. They are also an advocate for women in STEM and have demonstrated effective leadership in collaborative drug discovery projects.
This person is not in any teams
This person is not in any offices